谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 272 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
161P Fibroblast Activation Protein (FAP)-CD40 (RO7300490) Mediates Intratumoral DC Maturation and Modulation of the Tumor Microenvironment
I. Melero, B. Reis,M.J. Lostes Bardaji,I. Spanggaard, D.H. Lee, J. Spicer,F. Thistlethwaite,S.N. Symeonides,D-Y. Oh, A. Hollebecque,N. Rieder, P. Schwalie, S. Badillo, N. Kumpesa, A. Thommen,C. Rusterholz, O. Cirovic, G. Kazantzidis,V. Moreno Garcia, A. Epp
Annals of Oncology (2024)
引用0浏览0引用
0
0
First-line ADP-A2M4CD8 T-cell Receptor T-cell Therapy Plus Pembrolizumab in Head and Neck Cancers: an Additional Cohort of the Phase 1 SURPASS Trial
A. Ho, A. Garcia-Consuegra,J. Saro, A. Sauer, S. Cristiani, F.E. Brophy, S. Streets,E. Norry,M. Gillison,J. Charlson, M. Bover,J. Zugazagoitia, E. Calvo,L. Ugidos,G. Bruixola,V. Moreno Garcia,D.S. Hong, J. Rubio-Pérez,D.H. Aggen
International Journal of Radiation OncologyBiologyPhysicsno. 5 (2024): e84-e85
引用0浏览0引用
0
0
612O Preliminary Results from a Phase I Study of CFT1946, a Novel BIDAC Degrader in Mutant BRAF V600 Solid Tumors
M. Vieito,M. Mckean,A.I. Spira, E. Rosen, J. Rodon,V. Moreno Garcia,V. Gambardella, O. Saavedra, S. Cousin, P. Cassier,I. Korakis,B.A. Van Tine, V.T-L. Ma, A. Ali, E. Hinojosa, R. Lobbardi, H. Liu, E. Hurh,L. Reyno,E. Buchbinder
Annals of Oncology (2024)
引用0浏览0引用
0
0
750P Phase I Safety and Efficacy of Brenetafusp, a PRAME × CD3 ImmTAC T Cell Engager, in Platinum Resistant Ovarian Cancer (PROC)
C. Friedman, A. De Burgh Williams,J.S. Lopez,K. Ouali, M.R. Middleton,F. Thistlethwaite, O. Hamid,B. Izar,V. Moreno Garcia, M.L. Johnson,D. Davar,J. Martin-Liberal,P. Roxburgh, K.N. Moore, D. Olson, S. Rottey, P.B. Kirk, Y. Yuan, S. Marshall,O. Yeku
Annals of Oncology (2024)
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 275

#Citation: 6520

H-Index: 35

G-Index: 77

Sociability: 8

Diversity: 3

Activity: 289

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn